Petros Pharmaceuticals   Report issue

For profit Phase 2
Founded: Fort Lauderdale FL United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2014
NCT02221947
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Neurotrope Bioscience, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

bryostatin (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 1